New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities

Area of Science:

• Oncology
• Biomedical Engineering
• Urology

Background:

• Bladder cancer is a prevalent global malignancy.
• Current diagnostic methods like cystoscopy are invasive, costly, and lack sensitivity, leading to late diagnoses.
• Population-level screening for bladder cancer is not feasible with existing methods.

Purpose of the Study:

• To explore the development of a non-invasive biosensing approach for early bladder cancer detection.
• To identify universal urinary biomarkers for accurate and accessible bladder cancer diagnosis and monitoring.
• To discuss challenges and future directions for creating a sensitive bladder cancer biosensor.

Main Methods:

• Review of current research on bladder cancer diagnostics.
• Analysis of limitations of existing diagnostic tools (e.g., cystoscopy).
• Exploration of biosensing technologies and genetic assessment challenges for population screening.

Main Results:

• Current diagnostic methods result in late cancer detection.
• Genetic variations across populations hinder accurate genetic screening.
• The need for universal biomarkers in urine for effective biosensing is highlighted.

Conclusions:

• A non-invasive, rapid, and accurate biosensor test for bladder cancer is highly desirable.
• Such a biosensor could revolutionize early diagnosis, patient management, and reduce healthcare burdens.
• Further research is needed to identify suitable biomarkers for sensitive bladder cancer biosensor development.